Consenso multidisciplinar sobre prevención y tratamiento de la tuberculosis en pacientes candidatos a tratamiento biológico. Adaptación al paciente dermatológico

Author:

Rodríguez-Jiménez P.,Mir-Viladrich I.,Chicharro P.,Solano-López G.,López-Longo F.J.,Taxonera C.,Sánchez-Martínez P.,Martínez-Lacasa X.,García-Gasalla M.,Dorca J.,Arias-Guillén M.,García-García J.M.,Dauden E.

Publisher

Elsevier BV

Subject

Dermatology,Histology,Pathology and Forensic Medicine

Reference120 articles.

1. Tuberculosis global report 2017. World Health Organization [consultado Sep 2017]. Disponible en: www.who.int/tb

2. Incidence of tuberculosis infection in psoriatic patients on anti-TNF therapy: Report of a case series with 144 patients;Sánchez-Moya;J Eur Acad Dermatol Venereol.,2011

3. What can we learn by following the development of tuberculosis from one generation to another? 1930;Andvord;Int J Tuberc Lung Dis,2002

4. A method for estimating the prevalence of tuberculosis infection;Rust;Am J Epidemiol.,1975

5. Infliximab approval process in Crohn's disease. Deparment of Health and Human Services. Public Health Service. Food and Drug Administration; August 24, 1998.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3